comparemela.com

Latest Breaking News On - Frontline treatment advanced rcc - Page 1 : comparemela.com

Nivolumab Plus Ipilimumab Versus Sunitinib For First-Line Treatment of Advanced Renal Cell Carcinoma: Long-Term Follow-Up Data From the Phase 3 CheckMate 214 Trial

Nizar Tannir, MD, FACP, presents extended follow-up data assessing the combination of nivolumab and ipilimumab compared with sunitinib in the frontline setting of patients with advanced renal cell carcinoma (RCC).

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.